NCT06889623View on ClinicalTrials.gov

Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer

NARecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2028

Conditions
NMIBC
Interventions
PROCEDURE

Immediate postoperative chemotherapy

Systemic chemotherapy with cisplatin/gemcitabine intravenous infusion within 24 hours after TURBT

Trial Locations (1)

200000

RECRUITING

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER